Perkins Coie Trust Company’s Novo Nordisk NVO Stock Holding History

Perkins Coie Trust Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Hold	5,542	–	–	0.04%	94
2026 Q1	$204K	Hold	5,542	–	–	0.04%	103
2025 Q4	$282K	Hold	5,542	–	–	0.05%	89
2025 Q3	$308K	Hold	5,542	–	–	0.06%	85
2025 Q2	$383K	Sell	5,542 -3	-0.1%	-$204	0.07%	86
2025 Q1	$385K	Buy	5,545 +3	+0.1%	+$248	0.09%	83
2024 Q4	$477K	Hold	5,542	–	–	0.1%	80
2024 Q3	$660K	Hold	5,542	–	–	0.15%	76
2024 Q2	$791K	Hold	5,542	–	–	0.18%	67
2024 Q1	$712K	Sell	5,542 -10	-0.2%	-$1.19K	0.17%	70
2023 Q4	$574K	Hold	5,552	–	–	0.15%	75
2023 Q3	$505K	Buy	5,552 +10	+0.2%	+$881	0.14%	76
2023 Q2	$448K	Hold	5,542	–	–	0.13%	71
2023 Q1	$441K	Hold	5,542	–	–	0.13%	69
2022 Q4	$375K	Hold	5,542	–	–	0.12%	72
2022 Q3	$276K	Sell	5,542 -1,950	-26%	-$104K	0.11%	74
2022 Q2	$417K	Hold	7,492	–	–	0.15%	69
2022 Q1	$416K	Hold	7,492	–	–	0.13%	72
2021 Q4	$420K	Sell	7,492 -7,284	-49%	-$395K	0.12%	71
2021 Q3	$709K	Hold	14,776	–	–	0.22%	68
2021 Q2	$619K	Hold	14,776	–	–	0.19%	71
2021 Q1	$498K	Hold	14,776	–	–	0.17%	76
2020 Q4	$516K	Sell	14,776 -48	-0.3%	-$1.66K	0.18%	77
2020 Q3	$515K	Hold	14,824	–	–	0.21%	73
2020 Q2	$485K	Hold	14,824	–	–	0.2%	78
2020 Q1	$446K	Hold	14,824	–	–	0.23%	78
2019 Q4	$429K	Hold	14,824	–	–	0.18%	81
2019 Q3	$383K	Hold	14,824	–	–	0.17%	80
2019 Q2	$378K	Buy	14,824 +116	+0.8%	+$2.87K	0.17%	77
2019 Q1	$385K	Hold	14,708	–	–	0.18%	78
2018 Q4	$339K	Hold	14,708	–	–	0.18%	79
2018 Q3	$347K	Hold	14,708	–	–	0.16%	83
2018 Q2	$339K	Hold	14,708	–	–	0.17%	83
2018 Q1	$362K	Hold	14,708	–	–	0.18%	82
2017 Q4	$395K	Hold	14,708	–	–	0.2%	82
2017 Q3	$354K	Hold	14,708	–	–	0.18%	83
2017 Q2	$315K	Hold	14,708	–	–	0.17%	84
2017 Q1	$252K	Hold	14,708	–	–	0.15%	80
2016 Q4	$264K	Sell	14,708 -1,492	-9%	-$27K	0.16%	80
2016 Q3	$337K	Hold	16,200	–	–	0.21%	77
2016 Q2	$436K	Sell	16,200 -1,200	-7%	-$32.9K	0.29%	71
2016 Q1	$471K	Sell	17,400 -600	-3%	-$16.1K	0.32%	66
2015 Q4	$523K	Hold	18,000	–	–	0.39%	61
2015 Q3	$488K	Hold	18,000	–	–	0.39%	59
2015 Q2	$493K	Buy	+18,000	New	+$506K	0.37%	59

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Perkins Coie Trust Company's NVO Position: Q2 2026 in Review

Perkins Coie Trust Company held its Novo Nordisk (NVO) position steady in Q2 2026 at 5,542 shares worth $266K. The position accounts for 0.04% of the portfolio, ranked #94.

Perkins Coie Trust Company first reported a position in NVO in Q2 2015 and has held it in 45 quarters since. The position peaked at $791K in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Perkins Coie Trust Company held 5,542 shares of Novo Nordisk worth $266K as of Q2 2026.
Perkins Coie Trust Company left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.04% of Perkins Coie Trust Company's portfolio in Q2 2026, its #94 holding.
Perkins Coie Trust Company first reported a position in Novo Nordisk in Q2 2015 and has held it in 45 quarters since.
Perkins Coie Trust Company's Novo Nordisk position peaked at $791K in Q2 2024.
387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.